Sarah Cannon brings together physician-led blood cancer programs across the United States and United Kingdom to offer patients convenient access to care including blood and marrow transplants and clinical trials. Committed to the highest level of quality, our network delivers an unparalleled experience for those facing blood cancer.

Sarah Cannon is one of the world’s largest providers of blood and marrow transplant (BMT), conducting more than 1,200 transplants per year and 12,000 + transplants performed since inception of our first program.  In fact, recent data shows the Sarah Cannon Blood Cancer Network, with 5 FACT-accredited programs, is the largest provider of blood and marrow transplants in the United States, tracking ahead of all major academic medical centers and networks.

Austin

St. David’s South Austin Medical Center is a FACT accredited BMT program that performs autologous and Allogeneic transplants for hematologic malignancies. The blood and marrow stem cell transplant program was established at Methodist Hospital in 1993 and expanded to St. David’s South Austin Medical Center in 2014 to establish a comprehensive adult transplant program in Austin. The two sites operate together as one program by sharing common quality management processes, policies, procedures, physicians, nurse competencies and personnel.

Transplant types: Adult Autologous and Allogeneic Transplants - Related/Unrelated/Haploidentical

Learn more about Austin.

Dallas

Medical City’s Stem Cell Transplantation and Research Program, founded in 1994, performs both adult and pediatric stem cell transplants, including autologous and allogeneic. From clinical workup to transplantation, each facet of the stem cell program is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT). 

Transplant types: Adult and Pediatric Autologous, Allogeneic - Related/Unrelated/Haploidentical/UCB

Learn more about Dallas

Denver

Colorado Blood Cancer Institute (CBCI) Blood and Marrow Transplant Program is the leading provider for hematologic malignancy and stem cell transplant medicine in the Rocky Mountains and Great Plains regions. CBCI Blood and Marrow Transplant Program is the region’s largest transplant program, and has been continuously recognized as a leader in patient care and outcomes. The program cares for patients throughout the whole spectrum of hematologic malignancy and has many active clinical trials.

Transplant types: Adult Autologous, Allogeneic - Related/Unrelated/Haploidential/UCB

Learn more about Colorado Blood Cancer Institute.

Kansas City

Sarah Cannon Blood Cancer Center at Research Medical Center provides specialized care for patients with complex blood cancers. The program provides comprehensive outpatient services, a dedicated inpatient oncology unit supported by a multidisciplinary team of specialists and now offers blood and marrow transplants. Sarah Cannon Blood Cancer Center at Research Medical Center began its adult autologous blood and marrow transplant services in 2019 and is FACT eligible.

Transplant types: Adult Autologous

Learn more about Kansas City.

Nashville

The mission of the Sarah Cannon Center for Blood Cancer is to ensure access for patients with hematologic malignancies to compassionate, state-of-the-art care and clinically meaningful innovative therapies. The multidisciplinary team offers comprehensive management of newly diagnosed, relapsed, refractory, acute or chronic malignancies, through personalized treatment plans including standard of care and clinical trials. Sarah Cannon Center for Blood Cancer also began seeing pediatric transplant patients in 2015.

Transplant types: Adult and Pediatric Autologous, Allogeneic - Related/Unrelated/Haploidentical

Learn more about Nashville.

San Antonio

The Adult and Pediatric Blood Cancer and Stem Cell Transplant Program at Methodist Hospital and Methodist Children’s Hospital in San Antonio has performed nearly 3,000 transplants since the program’s inception in 1993. The program consistently ranks among the nation’s top transplant centers in one-year patient survival rates and was the first in North America to be accredited by the Foundation for the Accreditation of Cellular Therapy (FACT). 

Transplant types: Adult and Pediatric Autologous, Allogeneic - Related/Unrelated/Haploidentical/UCB

Learn more about our adult blood cancer and stem cell program.

More information about our pediatric program..


United Kingdom

The adult Blood Cancer and Stem Cell Transplant Program in the UK was established in 2006 in partnership with prestigious teaching hospitals. We partner with University College Hospital London, Guys and St Thomas’ in London and The Christie in Manchester. Each of these locations has received the highest rating of Outstanding from England’s health regulator The Care Quality Commission (CQC), this rating reflects the highest standard of safe and effective care.

Transplant types: Adult Autologous and Allogeneic Transplants Related/Unrelated/Haploidentical/UCB

HCA Healthcare UK at University College Hospital London (HCA UK at UCH)

The adult Blood Cancer and Stem Cell Transplant Program at HCA UK at UCH was established in 2006 in partnership with one of the UKs most prestigious teaching hospitals. The bone marrow and haematopoietic stem cell transplant service at University College Hospital is the largest transplant centre in Europe and provides a full range of transplant services. The private patient program achieved JACIE accreditation in 2009 and the highest rating of Outstanding from England’s health regulator The Care Quality Commission (CQC), this rating reflects the highest standard of safe and effective care.

Transplant types: Adult Autologous and Allogeneic Transplants Related/Unrelated/Haploidentical/UCB

The Christie Private Care, part of HCA Healthcare UK, in Manchester

HCA UK partnered with The Christie NHS Foundation Trust in 2010 to expand our UK blood network to Manchester in the North West of England, developing an adult Blood Cancer and Stem Cell Transplant Program. The Christie is one of Europe’s leading cancer centres recognised for its pioneering cancer research. The private patient program achieved JACIE accreditation in 2014 and the highest rating of Outstanding from England’s health regulator The Care Quality Commission (CQC), this rating reflects the highest standard of safe and effective care.

Transplant types: Adult Autologous and Allogeneic Transplants Related/Unrelated/Haploidentical/UCB

London Bridge Hospital, Private Care at Guys and St Thomas’, in London

In 2014 HCA UK partnered with Guy’s and St Thomas’ NHS Foundation Trust, which is co-located to our London Bridge Hospital campus. The adult stem cell transplant programme at this site currently focuses on autologous stem cell transplant for blood cancers and auto immune conditions. This program achieved JACIE accreditation in 2016 and as part of the London Bridge campus achieved the highest rating of Outstanding from England’s health regulator The Care Quality Commission (CQC). We are currently working with physicians to further develop this transplant programme, working towards allogeneic transplant services.

Transplant types: Adult Autologous

University Hospitals Birmingham, 2022

credit: Morley Von Sternberg

HCA Healthcare UK has partnered with University Hospitals Birmingham located in the centre of the West Midlands region of England. Construction is currently underway on a new hospital based on the Queen Elizabeth Hospital campus. Plans for the new hospital include the expansion of our blood network with a comprehensive adult bone marrow and stem cell transplant program.